Molecular Partners Ag (MOLN) Operating Margin Growth (3y) (2025)
Molecular Partners Ag (MOLN) Operating Margin Growth (3y) (2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | -2,649.00 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -10.13 Mn |